IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Therapeutic Advances in Psychopharmacology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

3.81

h-Index

2024-2025

 46

Rank

2024-2025

 3624

SJR

2024-2025

 1.187

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Therapeutic Advances in Psychopharmacology
Abbreviation Ther. Adv. Psychopharmacol.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)
h-index 46
Overall Rank/Ranking 3624
SCImago Journal Rank (SJR) 1.187
Impact Score 3.81
Publisher SAGE Publications Inc.
Country United Kingdom
ISSN 20451261, 20451253
Best Quartile Q1
Coverage History 2011-2024




About Therapeutic Advances in Psychopharmacology


Therapeutic Advances in Psychopharmacology is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by SAGE Publications Inc.. The overall rank of Therapeutic Advances in Psychopharmacology is 3624. According to SCImago Journal Rank (SJR), this journal is ranked 1.187. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 46. The best quartile for this journal is Q1.

The ISSN of Therapeutic Advances in Psychopharmacology journal is 20451261, 20451253. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Psychopharmacology is cited by a total of 498 articles during the last 3 years (Preceding 2024).


Therapeutic Advances in Psychopharmacology Impact IF 2024-2025


The Impact IF 2024 of Therapeutic Advances in Psychopharmacology is 3.81, which is computed in 2025 as per its definition. Therapeutic Advances in Psychopharmacology IF is increased by a factor of 0.36 and approximate percentage change is 10.43% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Therapeutic Advances in Psychopharmacology Impact IF 2025 Prediction


Impact IF 2024 of Therapeutic Advances in Psychopharmacology is 3.81. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Therapeutic Advances in Psychopharmacology. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 3.81
2023 3.45
2015 2.01
2014 1.32

Therapeutic Advances in Psychopharmacology h-index


  Table Setting

Therapeutic Advances in Psychopharmacology has an h-index of 46. It means 46 articles of this journal have more than 46 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Therapeutic Advances in Psychopharmacology ISSN


The ISSN of Therapeutic Advances in Psychopharmacology is 20451261, 20451253. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Therapeutic Advances in Psychopharmacology Rank and SCImago Journal Rank (SJR)


The overall rank of Therapeutic Advances in Psychopharmacology is 3624. According to SCImago Journal Rank (SJR), this journal is ranked 1.187. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Therapeutic Advances in Psychopharmacology by Year


Year SJR
2025/2026 Coming Soon
2024 1.187
2023 1.179
2015
2014

Ranking of Therapeutic Advances in Psychopharmacology by Year


Year Ranking
2025/2026 Coming Soon
2024 3624
2023 3396
2015 33695
2014 32957

Therapeutic Advances in Psychopharmacology Publisher


Table Setting

Therapeutic Advances in Psychopharmacology is published by SAGE Publications Inc.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2011-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Therapeutic Advances in Psychopharmacology is Ther. Adv. Psychopharmacol.. This abbreviation ('Ther. Adv. Psychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Therapeutic Advances in Psychopharmacology


If your research field is/are related to Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Therapeutic Advances in Psychopharmacology?

Therapeutic Advances in Psychopharmacology latest impact IF is 3.81. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.81 (2024) and 1.32 (2014), respectively, in the last 4 years. Moreover, its average IS is 2.65 in the previous 4 years.


What's the SCImago Journal Rank (SJR) of the Therapeutic Advances in Psychopharmacology?

The Therapeutic Advances in Psychopharmacology has an SJR (SCImago Journal Rank) of 1.187, according to the latest data. It is computed in the year 2025. In the past 4 years, this journal has recorded a range of SJR, with the highest being 1.187 in 2024 and the lowest being in 2015. Furthermore, the average SJR of the Therapeutic Advances in Psychopharmacology over the previous 4-year period stands at 2.65.


What's the latest h-index of the Therapeutic Advances in Psychopharmacology?

The latest h-index of the Therapeutic Advances in Psychopharmacology is 46.


Who's the publisher of the Therapeutic Advances in Psychopharmacology?

The Therapeutic Advances in Psychopharmacology is published by the SAGE Publications Inc., with its country of publication being the United Kingdom.


What's the current ranking of the Therapeutic Advances in Psychopharmacology?

The Therapeutic Advances in Psychopharmacology is currently ranked 3624 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this journal has experienced varying rankings, reaching its highest position of 3396 in 2023 and its lowest position of 33695 in 2015.


What's the abbreviation or short name for the Therapeutic Advances in Psychopharmacology?

The standard ISO4 abbreviation for the Therapeutic Advances in Psychopharmacology is Ther. Adv. Psychopharmacol..


Is the "Therapeutic Advances in Psychopharmacology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Therapeutic Advances in Psychopharmacology is classified as a journal that the SAGE Publications Inc. publishes.


What's the scope or major areas of the Therapeutic Advances in Psychopharmacology?

The Therapeutic Advances in Psychopharmacology encompasses the following areas:

  • Pharmacology (medical)
  • Psychiatry and Mental Health

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Therapeutic Advances in Psychopharmacology?

The Therapeutic Advances in Psychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 20451261, 20451253.


What's the best quartile of the Therapeutic Advances in Psychopharmacology?

The best quartile for the Therapeutic Advances in Psychopharmacology is Q1 (2024).


What's the coverage history of the Therapeutic Advances in Psychopharmacology?

The Therapeutic Advances in Psychopharmacology coverage history can be summarized as follows: 2011-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the ASME Turbo Expo conference and proceedings 17577 54 0.00
Analysis in Theory and Applications journal 19346 Springer Netherlands 11 0.00
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Journal, Indian Academy of Clinical Medicine journal 28559 Indian Academy of Clinical Medicine 16 0.10
Socialism and Democracy journal 27160 Taylor and Francis Ltd. 19 0.20
Indian Phytopathology journal 16772 Springer 20 0.91
Journal of Imaging Science and Technology journal 22021 Society for Imaging Science and Technology 45 0.61
Poljoprivreda journal 17375 Faculty of Agriculture in Osijek 16 1.31
HOMO- Journal of Comparative Human Biology journal 17447 Elsevier B.V. 40 1.17
Clinical Interventions in Aging journal 4023 Dove Medical Press Ltd. 114 3.68

Check complete list




Year wise Impact Score (IS) of Therapeutic Advances in Psychopharmacology

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 3.81
2023 3.45
2015 2.01
2014 1.32



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

Lancet Psychiatry,The
Elsevier Ltd | United Kingdom

Clinical Psychology Review
Elsevier Inc. | United States

JAMA Psychiatry
American Medical Association | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Lancet Healthy Longevity, The
Elsevier Ltd | United Kingdom

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Health Psychology Review
Routledge | United Kingdom

Molecular Psychiatry
Springer Nature | United Kingdom

See All